Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | %Female (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Protein and Cell | journal | 4.412 Q1 | 94 | 83 | 257 | 551 | 2693 | 152 | 12.12 | 6.64 | 42.80 | |
2 | Journal for ImmunoTherapy of Cancer | journal | 3.728 Q1 | 117 | 445 | 1590 | 19408 | 14743 | 1571 | 8.71 | 43.61 | 42.99 | |
3 | Emerging Microbes and Infections | journal | 2.316 Q1 | 94 | 248 | 807 | 10789 | 7054 | 668 | 7.83 | 43.50 | 43.75 | |
4 | npj Vaccines | journal | 2.127 Q1 | 47 | 182 | 421 | 9795 | 2689 | 404 | 6.60 | 53.82 | 45.87 | |
5 | Particle and Fibre Toxicology | journal | 2.019 Q1 | 119 | 49 | 177 | 3252 | 1705 | 176 | 7.12 | 66.37 | 45.71 | |
6 | Journal of Nanobiotechnology | journal | 1.840 Q1 | 109 | 478 | 1132 | 37071 | 12176 | 1131 | 10.46 | 77.55 | 41.81 | |
7 | International Journal of Neuropsychopharmacology | journal | 1.525 Q1 | 125 | 79 | 261 | 4188 | 1265 | 254 | 4.59 | 53.01 | 45.25 | |
8 | PharmacoEconomics | journal | 1.517 Q1 | 118 | 106 | 332 | 5784 | 1361 | 286 | 3.88 | 54.57 | 46.30 | |
9 | CNS Neuroscience and Therapeutics | journal | 1.473 Q1 | 91 | 418 | 491 | 24328 | 2516 | 434 | 4.95 | 58.20 | 43.37 | |
10 | Therapeutic Advances in Neurological Disorders | journal | 1.436 Q1 | 68 | 91 | 251 | 4803 | 1134 | 239 | 4.44 | 52.78 | 37.62 | |
11 | Expert Review of Vaccines | journal | 1.412 Q1 | 105 | 110 | 409 | 7915 | 2013 | 364 | 5.10 | 71.95 | 43.87 | |
12 | EPMA Journal | journal | 1.370 Q1 | 52 | 41 | 114 | 3583 | 830 | 111 | 7.32 | 87.39 | 43.01 | |
13 | npj Systems Biology and Applications | journal | 1.248 Q1 | 35 | 61 | 127 | 3945 | 467 | 126 | 3.68 | 64.67 | 32.92 | |
14 | Human Genomics | journal | 1.199 Q1 | 68 | 113 | 186 | 6418 | 681 | 176 | 3.51 | 56.80 | 49.55 | |
15 | Drug Delivery | journal | 1.155 Q1 | 95 | 119 | 642 | 8298 | 4560 | 641 | 6.69 | 69.73 | 42.43 | |
16 | Clinical and Translational Science | journal | 1.109 Q1 | 60 | 239 | 686 | 8534 | 2489 | 647 | 3.48 | 35.71 | 43.76 | |
17 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.949 Q1 | 92 | 212 | 573 | 12376 | 3394 | 573 | 5.93 | 58.38 | 43.02 | |
18 | Chinese Medicine | journal | 0.877 Q2 | 56 | 159 | 409 | 11306 | 2115 | 406 | 5.30 | 71.11 | 43.23 | |
19 | Journal of Occupational Medicine and Toxicology | journal | 0.868 Q1 | 47 | 31 | 109 | 1321 | 366 | 108 | 3.10 | 42.61 | 44.30 | |
20 | Pharmacology Research and Perspectives | journal | 0.790 Q1 | 43 | 112 | 456 | 3704 | 1368 | 443 | 2.93 | 33.07 | 44.55 | |
21 | Cardiovascular Therapeutics | journal | 0.769 Q2 | 54 | 34 | 165 | 1509 | 544 | 165 | 3.43 | 44.38 | 38.42 | |
22 | Pharmaceutical Biology | journal | 0.754 Q1 | 88 | 134 | 526 | 6483 | 2160 | 524 | 4.06 | 48.38 | 45.80 | |
23 | Journal of Pharmaceutical Policy and Practice | journal | 0.740 Q1 | 32 | 165 | 291 | 6518 | 936 | 256 | 2.71 | 39.50 | 44.97 | |
24 | BMC pharmacology & toxicology | journal | 0.710 Q2 | 43 | 77 | 253 | 2925 | 763 | 253 | 2.92 | 37.99 | 43.47 | |
25 | Drugs in R and D | journal | 0.708 Q2 | 54 | 40 | 111 | 1687 | 296 | 107 | 2.41 | 42.18 | 50.97 | |
26 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.696 Q2 | 57 | 27 | 169 | 1330 | 433 | 166 | 2.60 | 49.26 | 34.83 | |
27 | Environmental Pollutants and Bioavailability | journal | 0.659 Q2 | 39 | 53 | 114 | 3294 | 424 | 113 | 3.90 | 62.15 | 44.88 | |
28 | Advances in Pharmacological and Pharmaceutical Sciences | journal | 0.471 Q2 | 46 | 40 | 122 | 2294 | 361 | 122 | 2.52 | 57.35 | 48.99 | |
29 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.453 Q3 | 41 | 20 | 131 | 1498 | 307 | 131 | 2.19 | 74.90 | 51.58 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®